Positions

Overview

  • Dr Rogers received his AB degree in Biochemistry from Princeton University and MD degree from Johns Hopkins University School of Medicine. He did internal medicine residency at the Johns Hopkins Hospital, served two years in the U. S. Army Medical Corps in Vietnam and in El Paso, Texas, and then completed a fellowship in Cardiology at the University of Alabama Medical Center in 1975. He has since remained at UAB, has been Professor of Medicine since 1984 and served as Director of the Coronary Care Unit at University of Alabama Hospital for 27 years. He has been Principal Investigator for UAB for many pivotal collaborative clinical trials in cardiology including CASS, CAST, SOLVD, HERS, WISE, WAVE and multiple TIMI trials. He has been active in patient care and selected by peers on the Best Doctors in America List annually for 15 years.
  • Principal Investigator On

  • ELEVATE-TIMI 56: Escalating Clopidogrel by Involving a Genetic Strategy  awarded by Brigham and Women's Hospital
  • HPS 3/TIMI 55-Reveal (Randomized Evaluation of the Effects of Anacetrapib through Lipid-Modification)  awarded by Brigham and Women's Hospital
  • HPS 3/TIMI 55: REVEAL (Randomized EValuation of the Effects of Anacetrapib through Lipid-modification)  awarded by Brigham and Women's Hospital
  • PEGASUS:A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events with Ticagrelor Compared to Placebo on Background of Acetyl Salicylic Acid (ASA) Therapy in Patients with History of Myocardial Infarction  awarded by Brigham and Women's Hospital
  • Private Grant  awarded by ASTRAZENECA INTERNATIONAL
  • Private Grant  awarded by MERCK SHARP & DOHME CORP
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by SCHERING PLOUGH CORPORATION
  • Private Grant  awarded by ELI LILLY AND COMPANY
  • Private Grant  awarded by JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd.
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by Genentech
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by ELI LILLY AND COMPANY
  • Private Grant  awarded by Sanofi US Services Inc
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by EISAI, INC.
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by AMGEN, INC.^
  • SAVOR: Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus. A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial To Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stoke in Patients with Type 2 Diabetes  awarded by Brigham and Women's Hospital
  • SOLID TIMI 52: Stabilization of Plaques Using Darapladib--A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events  awarded by Brigham and Women's Hospital
  • Women's Ischemia Syndrome Evaluation National Death Index (WISE NDI)  awarded by University of Pittsburgh The
  • Education And Training

  • Johns Hopkins Hospital, Internship
  • Johns Hopkins Hospital, Residency
  • UAB Hospital, Postdoctoral Fellowship
  • Doctor of Medicine, Johns Hopkins University 1969
  • Certificate in Medicine, Princeton University 1965
  • Full Name

  • William Rogers